Navigation Links
Arm & Hand General Purpose Table

ProductsArm & Hand General Purpose Table
Company Allen Medical Systems
Item Arm & Hand General Purpose Table
Features 
  • Adjustable height
  • Square post
  • Clamps included
  • Includes a standard 1" (2.5 cm) pad
  • Replacement pads available
  • Description This table has adjustable height, square post and adjustable leg. Includes clamps, and standard 1" (2.5 cm) pad.
    Info Allen Medical Systems
    Customer Service: (800) 433-5774
    Web site: http://www.allenmedical.com

    Related medicine products :

    1. Mayfield General Purpose Headrest
    2. CXDI-40G General DR System
    3. 3M™ Steri-Drape™ General Orthopaedic Surgical Packs
    4. General Grasping Forceps
    5. Micro Oscillating Saw, General
    6. Platinum General Purpose Cautery Electrodes
    7. General Orthopaedics for PDA
    8. GF400 General Retractor
    9. GF450 General Retractor
    10. General Surgery ThermoWrap™
    11. Pocket General Surgery
    Barraquer needle holder, curved, delicate....
    Clinical micro clamps by Acland. Black finish. It provides impressive security in use, both against slippage and against leakage due to controlled closing force and working grip surface....
    Rhoton #12 straight point needle semisharp, titanium....
    Micro 2000, micro scissors micro 2000 supercut....
    Medicine Products:
    (Date:1/22/2015)... Payday lending practices in four southern ... financial distress to the states that permit them, according ... Center on Race and Wealth. , While they generate ... loans at the same time substantially depress economic activity, ...
    (Date:1/22/2015)... As interest in the value of spiritual support as ... Rev. Eric J. Hall , president and CEO of the ... the keynote speaker on January 27 at an international summit ... The conference, “Hope and Resilience: Innovative and Interdisciplinary Spiritual Care,” ...
    (Date:1/22/2015)... a new blog post presenting a list of vehicles that cannot ... Some types of vehicles cannot be covered under an ordinary auto ... see if their vehicle qualifies for auto insurance coverage. , ... that cannot be covered by a plan. Clients have little options ...
    (Date:1/22/2015)... (PRWEB) January 22, 2015 Step into ... at the Science Museum of Virginia. Wicked Plants, the ... Wicked Plants unearths 75 poisonous, carnivorous and diabolical plants ... each room to uncover the biochemical, physical and neurological ...
    (Date:12/26/2014)... December 26, 2014 The US represents the ... report. In 2013, GlobalData’s forecast estimates that sales of branded ... market due to the high incidence of the disease, high ... 5EU, Japan, and China. Increased sales of CRC therapies over ...
    Breaking Medicine News(10 mins):Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2Health News:Wicked Plants are taking over the Science Museum of Virginia 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 3Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 4
    ... class of breast cancer drugs, worked better than standard ... with advanced disease. Femara is a member of a ... differently to prevent certain kinds of breast cancer than ... better and helped more women survive. The US Food ...
    ... other vascular diseases are the leading causes of ... depiction of stenotic, occlusive, aneurismal, inflammatory or vascular ... are used to depict vascular lesions with high ... It is the gold standard with a very ...
    ... used in vitro fertilisation (IVF) technique intracytoplasmic sperm injection ... with abnormalities such as ambiguous genitalia. Researchers from the ... infertility is genetic are likely to have other, more ... spermatozoa are injected directly into the egg. // ...
    ... might overcome a major obstacle to treating brain ailments ... in rats, researchers from the Stroke Lab and Alzheimer's ... direct path from the nose to the brain” could ... foreign substances, including drugs. ,Senior investigator Dr. William ...
    ... The use of refined fossil fuels--especially kerosene, which is ... source--may cause sniffling, wheezing, itching, and other allergy symptoms. ... the fuels may somehow irritate the nasal lining and ... // ,The researchers studied the effects of ...
    ... out why women who have a baby when they are ... They have identified a substance produced naturally in the body ... the changes in the breast tissue of young women. The ... that could protect against breast cancer. ,In experiments, ...
    Cached Medicine News:Health News:Magnetic resonance angiography in clinical medicine 2Health News:Nasal Spray Could Take Drugs Directly to Brain 2
    (Date:1/23/2015)... , Jan. 23, 2015  MedScope ( www.medscope.org ), ... nominated for a 2015 Connected World magazine ... Response System (mPERS), that can be used anywhere, anytime. ... partner.  In nominating MedScope, Landon ...
    (Date:1/23/2015)... all-time hits leader, is the new spokesperson for the topical ... announced. "Pete,s a Hall of Famer in our ... with Myoflex," said Ducere Pharma Chief Executive Officer Chris ... across all generations. The passion and intensity that Pete brought ...
    (Date:1/23/2015)... N.Y. , Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. ... its Phase I trial of Lixte,s lead compound, LB‑100, is ... John S. Kovach , M.D., the founder ... planned to be completed at a single site. Accrual of ...
    Breaking Medicine Technology:MedScope Nominated by RacoWireless for Prestigious 2015 Connected World Magazine Connected World Award 2Pete Rose bets on Myoflex to relieve aches and pains 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3